Loading

16 Biotechnologie Stellen in Meyrin gefunden

Diese Jobsuche abonnieren
Bitte ausfüllen
Loading
Mit dem Absenden des Formulars erklären Sie sich mit unseren AGB und der Daten­schutz­erklärung einverstanden.
Bitte überprüfen Sie Ihren E-Mail Account, um die Anmeldung abzuschliessen.
Stellenbenachrichtigung
Loading
Stellenbenachrichtigung
Loading
Loading

Scientist Cancer Immunotherapy

bewerten
Bewertung abgegeben

AMAL Therapeutics is a Swiss biotech developing unique therapeutic vaccines, and a distinct unit of the Discovery Research organization of the Boehringer Ingelheim group. The company has developed a novel peptide/protein-based immunization technology platform, so-called KISIMA®, with the aim of stimulating the patient’s immune system for effective anti-cancer therapy. AMAL’s lead product, ATP128, is in clinical development for metastatic colorectal cancer since July 2019.

We are seeking talented and immunology driven scientist to join our dynamic team and contribute to the development of a new generation of anti-cancer vaccines.

Scientist Cancer Immunotherapy

AMAL Therapeutics is a Swiss biotech developing unique therapeutic vaccines, and a distinct unit of the Discovery Research organization of the Boehringer Ingelheim group. The company has developed a novel peptide/protein-based immunization technology platform, so-called KISIMA®, with the aim of stimulating the patient’s immune system for effective anti-cancer therapy. AMAL’s lead product, ATP128, is in clinical development for metastatic colorectal cancer since July 2019.

We are seeking talented and immunology driven scientist to join our dynamic team and contribute to the development of a new generation of anti-cancer vaccines.


In this position you will be responsible for planning, performing and interpreting the laboratory-based experiments to generate pre-clinical proof-of-principle and mode-of-action datasets, which are required to support the development of therapeutic vaccine candidates.

Job duties include, but are not limited to:

  • Designing and performing hands-on bench work to evaluate new cancer vaccine strategies in tumor models
  • Performing a wide range of experiments from molecular biology to cellular immunology, including flow cytometry, ELISPOT, ELISA, Immunohistochemistry, LUMINEX technology
  • Compiling and analyzing data, writing procedures, reports, manuscripts and other protocols

Technical requirements:

  • PhD or MS in immunology or related field
  • 3 to 5 years of experience in immunology, immuno-oncology
  • Experience in in vivo experiments and ex-vivo assays (cell purification, stimulation, etc.) is mandatory
  • Extensive experience in multi-parameter flow cytometry (FACS), including the ability to design, execute, analyze and interpret experiments 
  • In particular, skills in the functional analysis of immunity (e.g. proliferation, cytokine release, phenotyping, tumor microenvironment analysis, etc.)

Other skills:

  • High level of technical proficiency, initiative, independent thought, and collaborative ability
  • Excellent laboratory, organizational, communication and analytical skills
  • Fluent verbal and written communication skills in English
  • Fast learner, flexible and able to handle several tasks in parallel

 

Adresse

Avenue de la Roseraie 64 1205 Genève

Website http://www.amaltherapeutics.com

1205 Genève / Genève

Bewertung hinzufügen

Geben Sie hier Ihre Bewertung für die Firma Amal Therapeutics SA ab!

Bewertung abgegeben